1 |
Chlorhexidine Gluconate, Metronidazole & Lignocaine Hydrochloride Gel |
Composition :-
Chlorhexidine Gluconate Solution
Equ. to Chlorhexidine
Metronidazole
Equ. to Metronidazole
Lignocaine Hydrochloride
Gel Base |
IP
IP
IP |
1%w/w
1%w/w
2%w/w
q.s. |
2 |
Choline Salicylate & Lignocaine Hydrochloride Gel |
Composition :
Choline Salicylate Solution
Equ. to Choline Salicylate
Lignocaine Hydrochloride
Preservative:
Benzalkonium Chloride
In Pleasant Flavoured Base |
BP
IP
IP |
8.7%w/w
2.0%w/w
0.01%w/w
q.s |
3 |
Choline Salicylate, Lignocaine Hydrochloride and Benzalkonium Chloride Gel |
Composition :
Choline Salicylate Solution
Equ. to Choline Salicylate
Lignocaine Hydrochloride
Benzalkonium Chloride
In a Flavoured Mucoadhesive gel base |
BP
IP
IP |
8.7%w/w
2.0%w/w
0.01%w/w
q.s |
4 |
Clindamycin & NicotinamideGel |
Composition:
Clindamycin Phosphate
Equivalent toClindamycin
Nicotinamide
Gel base |
IP
IP |
1.0% w/w
4.0% w/w
q.s. |
5 |
Clindamycin Phosphate & AdapaleneGel |
Composition
Clindamycin phosphate
Equivalent to clindamycin
Adapalene
Gel base |
IP
IP |
1 % w/w
0.1%w/w
q.s. |
6 |
Clindamycin PhosphateGel |
Composition:-
Clindamycin Phosphate
Equivalent toClindamycin
Benzoyl PeroxideAnhydrous
Gel Base |
IP
IP |
1.00% w/w
2.50% w/w |
7 |
Diclofenac Diethyl amine, methyl Salicylate, linseed Oil &Menthol Gel |
Composition:-
Diclofenac Diethyl amine
Equ. toDiclofenacSodium 1.0%w/w)
Linseed Oil
Methyl Salicylate
Menthol
Benzyl Alcohol
Excipients |
IP
BP
IP
IP
IP |
1.16%w/w
3.0%w/w
10.0%w/w
5.0%w/w
1.0%w/w
q.s. |
8 |
Diclofenac Diethylamine , Thiocolchicoside, Virgin Linseed Oil, Methyl Salicylate & Menthol Gel |
Composition :
Diclofenac Diethylamine
Equ. to Diclofenac Sodium
Thiocolchicoside
Virgin Linseed Oil
Menthol
Methyl Salicylate
Preservative :
Benzyl Alcohol
Gel Base |
IP
IP
BP
IP
IP
IP |
1.16%w/w
1.00%w/w
0.125%w/w
3.0%w/w
5.0%w/w
10%w/w
1.0%w/w
q.s. |
9 |
Diclofenac, Methyl Salicylate & Menthol Topical Gel |
Diclofenac Diethylamine
Eq. to Diclofenac Sodium
Methyl Salicylate
Menthol
Benzyl Alcohol
(As Preservative)
Gel Base |
IP
IP
IP
IP
IP |
2.32% w/w
2% w/w
10% w/w
5% w/w
1% w/w
q.s |
10 |
Etoricoxib,Linse ed Oil,Methyl Salicylate & Menthol Gel |
Etoricoxib
Linseed Oil
Methyl Salicylate
Menthol |
IP
BP
IP
IP |
1.0% W/W
3.0% W/W
10.0% W/W
5.0% W/W
q.s. |
11 |
Fluoride Medicated Oral Gel |
Composition :
Sodium Monofluorophosphate
In a Flavoured Gel base
Approved Colour used |
USP |
0.35%w/w
q.s |
12 |
Itraconazole Gel |
Composition
Itraconazole
Methyl Paraben
Propyl Paraben
In Gel base |
BP
IP
IP |
1 % w/w
0.1% w/w
0.05% w/w
q.s. |
13 |
Lipid Based Amphotericin B Gel 0.1% w/w |
Each g contains:
Amphotericin B
Base |
IP |
1.0mg
q.s. |
14 |
Virgin Linseed Oil, Diclofenac Diethylamine, Methyl Salicyclate, Menthol& Capsaicin Gel |
Composition:
Virgin Linseed Oil
Diclofenac Diethylamine
Equ. to Diclofenac Sodium
Methyl Salicyclate
Menthol
Capsaicin
Preservative :
Benzyl Alcohol
Gel Base |
BP
IP
IP
IP
USP
IP |
3.00%w/w
1.16%w/w
1.00%w/w
10.00%w/w
5.00%w/w
0.025%w/w
1.00%w/w
q.s. |